Harvard Bioscience, Inc.
Harvard Bioscience, Inc. (HBIO) Stock Overview
Explore Harvard Bioscience, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
21.2M
P/E Ratio
-0.38
EPS (TTM)
$-1.21
ROE
-3.89%
HBIO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Harvard Bioscience, Inc. (HBIO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 38.48, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.38 and a market capitalization of 21.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.